Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

108 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Targeting lymphangiogenesis to prevent tumour metastasis.
Achen MG, Mann GB, Stacker SA. Achen MG, et al. Br J Cancer. 2006 May 22;94(10):1355-60. doi: 10.1038/sj.bjc.6603120. Br J Cancer. 2006. PMID: 16641900 Free PMC article. Review.
Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development.
Achen MG, Gad JM, Stacker SA, Wilks AF. Achen MG, et al. Growth Factors. 1997;15(1):69-80. doi: 10.3109/08977199709002113. Growth Factors. 1997. PMID: 9401819
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).
Achen MG, Jeltsch M, Kukk E, Mäkinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA. Achen MG, et al. Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):548-53. doi: 10.1073/pnas.95.2.548. Proc Natl Acad Sci U S A. 1998. PMID: 9435229 Free PMC article.
The vascular endothelial growth factor family; proteins which guide the development of the vasculature.
Achen MG, Stacker SA. Achen MG, et al. Int J Exp Pathol. 1998 Oct;79(5):255-65. doi: 10.1046/j.1365-2613.1998.700404.x. Int J Exp Pathol. 1998. PMID: 10193309 Free PMC article. Review.
The vascular endothelial growth factor family: signalling for vascular development.
Stacker SA, Achen MG. Stacker SA, et al. Among authors: achen mg. Growth Factors. 1999;17(1):1-11. doi: 10.3109/08977199909001058. Growth Factors. 1999. PMID: 10495958 Review. No abstract available.
Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers.
Stacker SA, Stenvers K, Caesar C, Vitali A, Domagala T, Nice E, Roufail S, Simpson RJ, Moritz R, Karpanen T, Alitalo K, Achen MG. Stacker SA, et al. Among authors: achen mg. J Biol Chem. 1999 Nov 5;274(45):32127-36. doi: 10.1074/jbc.274.45.32127. J Biol Chem. 1999. PMID: 10542248
A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability.
Stacker SA, Vitali A, Caesar C, Domagala T, Groenen LC, Nice E, Achen MG, Wilks AF. Stacker SA, et al. Among authors: achen mg. J Biol Chem. 1999 Dec 3;274(49):34884-92. doi: 10.1074/jbc.274.49.34884. J Biol Chem. 1999. PMID: 10574962
Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3.
Achen MG, Roufail S, Domagala T, Catimel B, Nice EC, Geleick DM, Murphy R, Scott AM, Caesar C, Makinen T, Alitalo K, Stacker SA. Achen MG, et al. Eur J Biochem. 2000 May;267(9):2505-15. doi: 10.1046/j.1432-1327.2000.01257.x. Eur J Biochem. 2000. PMID: 10785369
VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues.
Partanen TA, Arola J, Saaristo A, Jussila L, Ora A, Miettinen M, Stacker SA, Achen MG, Alitalo K. Partanen TA, et al. Among authors: achen mg. FASEB J. 2000 Oct;14(13):2087-96. doi: 10.1096/fj.99-1049com. FASEB J. 2000. PMID: 11023993
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.
Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H, Achen MG. Stacker SA, et al. Among authors: achen mg. Nat Med. 2001 Feb;7(2):186-91. doi: 10.1038/84635. Nat Med. 2001. PMID: 11175849
108 results
Jump to page
Feedback